SEC Filing Summary: Owens & Minor, Inc. (10-Q)
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for Owens & Minor, Inc., a medical supply distributor, for the period ended March 31, 2010. The company operates as a large accelerated filer. On March 31, 2010, the company effected a three-for-two stock split. The financial statements exclude the direct-to-consumer diabetes supply (DTC) business, which was divested in January 2009 and is reported as discontinued operations.
Key Financial Metrics
| Metric | Q1 2010 | Q1 2009 |
|---|---|---|
| Revenue | $1,969.7 million | $1,948.6 million |
| Gross Margin | $190.5 million (9.67%) | $183.6 million (9.42%) |
| Operating Earnings | $49.2 million (2.50%) | $39.9 million (2.05%) |
| Net Income | $27.8 million | $14.0 million |
| Diluted EPS (Continuing Ops) | $0.44 | $0.36 |
| Cash from Operations | $139.5 million | $83.1 million |
| Cash and Equivalents | $146.4 million | $10.5 million |
| Long-Term Debt | $208.2 million | $208.4 million |
| Revolving Credit Facility | $0 outstanding; $295.1M available | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 1.1% year-over-year, driven by a 3.2% increase in sales to existing customers and $50.6 million in new customer sales, partially offset by an $87.7 million decrease in sales to lost customers due to economic conditions.
- Profitability: Operating earnings rose 23% to $49.2 million, primarily due to a 25 basis point increase in gross margin percentage and a 3.0% reduction in Selling, General, and Administrative (SG&A) expenses.
- Expense Management: SG&A expenses decreased to $135.2 million, aided by lower IT outsourcing costs, reduced labor costs, and lower fuel/freight costs compared to the prior year.
- Liquidity: Cash and cash equivalents increased significantly by $50.2 million to $146.4 million, driven by strong operating cash flow ($139.5 million) and a reduction in drafts payable.
- Discontinued Operations: Unlike Q1 2009, which included an $8.4 million loss from the divested DTC business, Q1 2010 had no income or loss from discontinued operations.
Outlook, Risks, and Management Commentary
- Capital Resources: The company has $200 million in senior notes maturing in 2016 and a $306 million revolving credit facility expiring in May 2011. Management is refinancing the credit facility, targeting completion in Q2 2010.
- Pension Plan: The company contributed $5.0 million to its defined benefit pension plan in Q1 2010 as part of a termination plan. Additional contributions of $3.0 million to $8.0 million are expected through late 2010 or early 2011.
- Dividends: Cash dividends paid were $0.177 per share in Q1 2010, up from $0.153 in Q1 2009. The company anticipates continuing quarterly dividends.
- Risk Factors: Key risks include the impact of the Patient Protection and Affordable Care Act (signed March 2010), potential reductions in healthcare reimbursement, supplier price volatility, and the ability of customers to meet financial commitments.
- Contingencies: The company has $6.8 million in contingent obligations related to contractual performance targets, none of which are currently accrued as they are not considered probable. A California sales tax incentive review is ongoing, with potential retrospective payments up to $1.05 million per quarter.
Investor Verification Checklist
- Verify the status and terms of the revolving credit facility refinancing targeted for Q2 2010.
- Monitor the impact of the Affordable Care Act on hospital utilization trends and customer purchasing behavior.
- Review the timeline and final cost of the defined benefit pension plan termination.
- Assess the resolution of the California sales tax incentive administrative review.
- Track the company's ability to offset lost customer sales with new customer acquisition in a challenging economic environment.